PIK3CD and depressive symptom measurement: The results indicated that among the top 20 pathways of PPT for depression, chemical carcinogenesis-receptor activation pathways in cancer, the prolactin signaling pathway, the PI3K-AKT signaling pathway, and endocrine resistance should be the focus of further research.